Gamida Cell Ltd (fka GMDAQ)

[midastouch017]

Gamida Cell Ltd. (NASDAQ:GMDA) Given Consensus Rating of "Buy" by Brokerages

https://www.marketbeat.com/instant-alerts/nasdaq-gmda-consensus-analyst-rating-2022-03-2-3/

MONDAY, MARCH 21, 2022 | MARKETBEAT
Gamida Cell logoGamida Cell Ltd. (NASDAQ:GMDA - Get Rating) has been given an average recommendation of "Buy" by the seven brokerages that are covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $13.39.

Several equities research analysts recently issued reports on the stock. Zacks Investment Research raised shares of Gamida Cell from a "hold" rating to a "buy" rating and set a $3.75 price objective for the company in a research note on Thursday, February 3rd. HC Wainwright reaffirmed a "buy" rating and set a $22.00 price objective on shares of Gamida Cell in a report on Wednesday, March 16th. Finally, JMP Securities reissued a "buy" rating and set a $17.00 target price on shares of Gamida Cell in a research report on Tuesday, February 1st.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in GMDA. Stonepine Capital Management LLC increased its stake in Gamida Cell by 288.8% during the third quarter. Stonepine Capital Management LLC now owns 1,724,201 shares of the company's stock valued at $6,759,000 after acquiring an additional 1,280,694 shares during the period. Altshuler Shaham Ltd lifted its position in Gamida Cell by 93,785.0% in the third quarter. Altshuler Shaham Ltd now owns 499,468 shares of the company's stock worth $1,968,000 after purchasing an additional 498,936 shares during the period. Marshall Wace LLP acquired a new stake in Gamida Cell during the third quarter worth $1,463,000. Renaissance Technologies LLC increased its holdings in Gamida Cell by 153.3% in the 3rd quarter. Renaissance Technologies LLC now owns 531,184 shares of the company's stock valued at $2,082,000 after buying an additional 321,484 shares during the period. Finally, Yahav Achim Ve Achayot Provident Funds Management Co Ltd. bought a new stake in Gamida Cell in the 3rd quarter valued at $686,000. Institutional investors and hedge funds own 53.43% of the company's stock.